Bio/Pharma News

Pfizer Announces PCSK9 Competitive Grants Program

April 10, 2015

The grants will be offered to investigators conducting research in the field of PCSK9 biology.

Mylan Offers $29 Billion for Perrigo

April 08, 2015

Mylan announces that it would offer Perrigo $29 billion in cash and stock to buy the Irish company.

ISPE Announces 2015 Facility of the Year Category Winners

April 06, 2015

Facilities in China, Ireland, Germany, and the United States have been recognized by ISPE in the 2015 Facility of the Year Awards program.

GSK Announces US Vaccine R&D Center

April 03, 2015

GlaxoSmithKline announces global vaccines research and design facility to be based in Rockville, MD, USA.

An Orthogonal Approach to Biosimilarity

April 02, 2015

In this article, industry experts discuss critical analyses for demonstrating biosimilarity.

Merck Joins CAR T-cell Market with $941 Million Intrexon Alliance

March 31, 2015

Merck Serono announces that it will work with Intrexon to develop a cancer therapy using chimeric antigen receptor T-cells.

Horizon Offers $1.1 Billion for Hyperion

March 30, 2015

Horizon Pharma offers to buy Hyperion Therapeutics for $1.1 billion in cash.

Novartis Inks $250 Million Alliance with Aduro

March 30, 2015

Novartis announced that it entered into a multiyear alliance with Aduro Biotech to develop cancer immunotherapies, offering up to $250 million in upfront payments and equity investments.

BMS Acquires Autoimmune Portfolio from Novo Nordisk

March 26, 2015

Bristol-Myers Squibb acquired an exclusive license for Novo Nordisk’s discovery biologics research program.

Genentech Expands Oregon Fill/Finish Site

March 26, 2015

Genentech plans to invest more than $125 million in an expansion of its fill/finish facility in Hillsboro, OR.